Gamida Cell to Participate in Two Upcoming Healthcare Conferences in New York City
BOSTON--(BUSINESS WIRE)--May 9, 2019--Gamida Cell Ltd. (Nasdaq: GMDA), a leading cellular and immune therapeutics company, today announced that the company will participate in two upcoming healthcare conferences taking place in New York City during May.
On Thursday, May 16, 2019, members of Gamida Cell’s management team will participate in investor meetings at the Oppenheimer & Co. Oncology Insight Summit.
Additionally, Julian Adams, Ph.D., chief executive officer of Gamida Cell, will participate in a “fireside chat” at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 21, 2019, at 11:00 a.m. ET. A live webcast of the presentation will be available on the Investors section of the Gamida Cell website, www.gamida-cell.com.
About Gamida Cell
Gamida Cell is a clinical-stage biopharmaceutical company committed to developing advanced cell therapies with the potential to cure blood cancers and rare, serious hematologic diseases. We are leveraging our proprietary nicotinamide-based, or NAM-based, cell expansion technology to develop product candidates designed to address the limitations of cell therapies. For additional information, please visit www.gamida-cell.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190509005112/en/
CONTACT: Jaren Irene Madden
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL
SOURCE: Gamida Cell Ltd.
Copyright Business Wire 2019.
PUB: 05/09/2019 08:31 AM/DISC: 05/09/2019 08:31 AM